Another possible explanation of why myCAF-produced COL-I might not contribute significantly to ICC growth involves the apparent abundance of myCAF observed recently in the late stage of ICC combined with driving ICC progression via Igf1/Igfr signaling (19). The gene discussed is IGF1; the disease is intrahepatic cholangiocarcinoma.